Karin Ann Thacker
Conseiller Juridique Général chez SENTI BIOSCIENCES, INC.
Provenance du réseau au premier degré de Karin Ann Thacker
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
| Public Company | Biotechnology | 8 | |
| Public Company | Biotechnology | 7 | |
| Public Company | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Karin Ann Thacker via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Founder Founder Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member Founder Founder | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder Founder | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Corvium, Inc.
 Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Packaged Software | Founder Founder | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Private Equity Investor Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| Xira Connect, Inc. | Director/Board Member | ||
| VAXART, INC. | Biotechnology | Chief Executive Officer | |
Valitor, Inc.
 Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer | |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Medical Specialties | Founder | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Kaiser Permanente Washington Health Research Institute
 Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Kaiser Permanente Washington Health Research Institute is a non profit organization that provides healthcare plans and services. It focuses on total health of its members and guided by personal physicians, specialists, and team of caregivers. Its expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, care delivery, and chronic disease management. The company was founded in 1983 and is headquartered in Seattle, WA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of California, Davis | College/University | Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
Eligo Bioscience SA
 Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Medical/Nursing Services | Founder | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The California Academy of Sciences operates as a scientific and cultural institution. The Academy houses an aquarium, a planetarium a natural history museum and a rainforest. It was founded in 1853 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| GUARDANT HEALTH, INC. | Medical/Nursing Services | Director/Board Member | |
| Genentech Access To Care Foundation | Chairman | ||
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| Xlink Therapeutics, Inc. | Founder | ||
ImmuRx, Inc.
 ImmuRx, Inc. BiotechnologyHealth Technology ImmuRx, Inc. develops adjuvant platforms for the treatment of cancer and infectious disease. Its product includes CD40 compound, an antibody. The company was founded by Randolph J. Noelle and Ross Kedl in 2005 and is headquartered in Lebanon, NH. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Gene Solutions LLC
 Gene Solutions LLC BiotechnologyHealth Technology Gene Solutions LLC conducts therapeutic drug discovery research for central nervous system diseases by utilizing its proprietary mitochondrial genomic targets. It delivers mitochondrial therapeutic solutions and choices for pharmaceutical and biotechnology companies to enhance their drug pipelines in the field of Alzheimer’s, Parkinson’s, and schizophrenia diseases. The company was founded in 2006 by William Davis Parker Jr. and Edward P Connell and is headquartered in Charlottesville, VA. | Biotechnology | Director/Board Member | |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member | |
Serenex, Inc.
 Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
Waratah Pharmaceuticals, Inc.
 Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million. | Medical Specialties | Founder |
Statistiques
Internationale
| Etats-Unis | 46 |
| Royaume-Uni | 3 |
| France | 2 |
| Pays-Bas | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Health Services | 4 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 176 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 62 |
| Founder | 33 |
| Chief Tech/Sci/R&D Officer | 31 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Elaine Jones | 37 |
| Alan Colowick | 30 |
| James Collins | 25 |
| Peter Svennilson | 25 |
| Timothy Lu | 16 |
| Judith Li | 15 |
| Omid Farokhzad | 15 |
| Steve Krognes | 14 |
| Gerald McMahon | 13 |
| Natalie Sacks | 13 |
| Adrian Senderowicz | 13 |
| Richard Benton Phillips | 13 |
| Patrick Mahaffy | 13 |
| Kanya Rajangam | 11 |
- Bourse
- Insiders
- Karin Ann Thacker
- Connexions Sociétés
